Pricing
Login
Home
Charts
Search
Watchlist
Products

Lincoln Pharmaceuticals Ltd

LINCOLN
₹511.90-0.03%20 Nov 2026
Reports
Pharma Formulations

Lincoln Pharmaceuticals Ltd

LINCOLN
₹511.90
-0.03%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,025Cr
Close
Close Price
₹511.90
Industry
Industry
Pharma Formulations
PE
Price To Earnings
10.58
PS
Price To Sales
1.42
Revenue
Revenue
₹722Cr
Rev Gr TTM
Revenue Growth TTM
14.25%
PAT Gr TTM
PAT Growth TTM
21.10%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
146142147161147168154163166187177191
Growth YoY
Revenue Growth YoY%
9.526.78.63.40.118.04.61.313.511.415.117.1
Expenses
ExpensesCr
117124125133123141130138143162150168
Operating Profit
Operating ProfitCr
301823282427242524252724
OPM
OPM%
20.312.915.417.616.115.915.415.614.213.315.512.4
Other Income
Other IncomeCr
11710109-715715-42410
Interest Expense
Interest ExpenseCr
010010000000
Depreciation
DepreciationCr
333333344444
PBT
PBTCr
382229352916352935174829
Tax
TaxCr
10468858965119
PAT
PATCr
281924262112282029123620
Growth YoY
PAT Growth YoY%
29.848.124.5-4.8-25.9-37.716.9-24.137.70.430.92.3
NPM
NPM%
19.113.116.116.314.26.918.012.217.26.220.410.7
EPS
EPS₹
14.09.311.813.210.45.813.810.014.35.818.110.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
146142147161147168154163166187177191
Growth YoY
Revenue Growth YoY%
9.526.78.63.40.118.04.61.313.511.415.117.1
Expenses
ExpensesCr
117124125133123141130138143162150168
Operating Profit
Operating ProfitCr
301823282427242524252724
OPM
OPM%
20.312.915.417.616.115.915.415.614.213.315.512.4
Other Income
Other IncomeCr
11710109-715715-42410
Interest Expense
Interest ExpenseCr
010010000000
Depreciation
DepreciationCr
333333344444
PBT
PBTCr
382229352916352935174829
Tax
TaxCr
10468858965119
PAT
PATCr
281924262112282029123620
Growth YoY
PAT Growth YoY%
29.848.124.5-4.8-25.9-37.716.9-24.137.70.430.92.3
NPM
NPM%
19.113.116.116.314.26.918.012.217.26.220.410.7
EPS
EPS₹
14.09.311.813.210.45.813.810.014.35.818.110.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
400360361366386424472510581623671722
Growth
Revenue Growth%
50.4-10.00.11.55.69.811.38.113.87.37.714.3
Expenses
ExpensesCr
360313308299321337377421481522573623
Operating Profit
Operating ProfitCr
414752676687958910010198100
OPM
OPM%
10.113.014.518.417.020.620.217.517.216.314.613.8
Other Income
Other IncomeCr
7356116102234223345
Interest Expense
Interest ExpenseCr
1075422121211
Depreciation
DepreciationCr
5667788911131515
PBT
PBTCr
33374662678496100122109116128
Tax
TaxCr
9912131621272829272831
PAT
PATCr
242835495162697393828897
Growth
PAT Growth%
58.218.223.240.75.620.911.45.128.0-11.76.721.1
NPM
NPM%
6.07.89.613.313.314.714.714.316.113.213.113.4
EPS
EPS₹
14.515.717.324.425.731.134.636.446.641.143.948.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
400360361366386424472510581623671722
Growth
Revenue Growth%
50.4-10.00.11.55.69.811.38.113.87.37.714.3
Expenses
ExpensesCr
360313308299321337377421481522573623
Operating Profit
Operating ProfitCr
414752676687958910010198100
OPM
OPM%
10.113.014.518.417.020.620.217.517.216.314.613.8
Other Income
Other IncomeCr
7356116102234223345
Interest Expense
Interest ExpenseCr
1075422121211
Depreciation
DepreciationCr
5667788911131515
PBT
PBTCr
33374662678496100122109116128
Tax
TaxCr
9912131621272829272831
PAT
PATCr
242835495162697393828897
Growth
PAT Growth%
58.218.223.240.75.620.911.45.128.0-11.76.721.1
NPM
NPM%
6.07.89.613.313.314.714.714.316.113.213.113.4
EPS
EPS₹
14.515.717.324.425.731.134.636.446.641.143.948.4
Sales CAGR
1 Year8%
3 Years10%
5 Years10%
TTM14%
EBITDA CAGR
1 Year-4%
3 Years3%
5 Years2%
TTM0%
PAT CAGR
1 Year7%
3 Years6%
5 Years7%
TTM21%
Avg. ROCE
1 Year15%
3 Years18%
5 Years19%
TTM16%
CFO / EBITDA
1 Year109%
3 Years88%
5 Years78%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
162020202020202020202020
Reserves
ReservesCr
117172204249293346413482573652738792
Current Liabilities
Current LiabilitiesCr
10091105856676907292106111127
Non Current Liabilities
Non Current LiabilitiesCr
342218111010111315192226
Total Liabilities
Total LiabilitiesCr
275305347366389452534587700797890964
Current Assets
Current AssetsCr
147181218224248309353367447500583643
Non Current Assets
Non Current AssetsCr
128124129142141144182220254297307321
Total Assets
Total AssetsCr
275305347366389452534587700797890964
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
162020202020202020202020
Reserves
ReservesCr
117172204249293346413482573652738792
Current Liabilities
Current LiabilitiesCr
10091105856676907292106111127
Non Current Liabilities
Non Current LiabilitiesCr
342218111010111315192226
Total Liabilities
Total LiabilitiesCr
275305347366389452534587700797890964
Current Assets
Current AssetsCr
147181218224248309353367447500583643
Non Current Assets
Non Current AssetsCr
128124129142141144182220254297307321
Total Assets
Total AssetsCr
275305347366389452534587700797890964

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
45252753756976396393106
Investing Cash Flow
Investing Cash FlowCr
-42-25-12-18-31-64-78-37-57-79-98
Financing Cash Flow
Financing Cash FlowCr
-30-11-36-38-6-3-5-5-60
Net Cash Flow
Net Cash FlowCr
003-17-1-5-2188
Free Cash Flow
Free Cash FlowCr
117173868613126247482
CFO To PAT
CFO To PAT%
188.289.076.9108.4146.5111.3109.853.967.8113.0121.0
CFO To EBITDA
CFO To EBITDA%
110.553.550.978.6115.179.579.744.063.391.7108.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
45252753756976396393106
Investing Cash Flow
Investing Cash FlowCr
-42-25-12-18-31-64-78-37-57-79-98
Financing Cash Flow
Financing Cash FlowCr
-30-11-36-38-6-3-5-5-60
Net Cash Flow
Net Cash FlowCr
003-17-1-5-2188
Free Cash Flow
Free Cash FlowCr
117173868613126247482
CFO To PAT
CFO To PAT%
188.289.076.9108.4146.5111.3109.853.967.8113.0121.0
CFO To EBITDA
CFO To EBITDA%
110.553.550.978.6115.179.579.744.063.391.7108.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2564724214252684496236781,1731,1051,1301,025
Price To Earnings
Price To Earnings
11.016.812.28.75.27.29.09.312.613.412.910.6
Price To Sales
Price To Sales
0.61.31.21.20.71.11.31.32.01.81.71.4
Price To Book
Price To Book
1.92.51.91.60.81.21.41.42.01.61.51.3
EV To EBITDA
EV To EBITDA
7.911.18.86.73.95.06.37.211.610.711.310.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.134.541.045.446.448.048.547.046.146.947.447.4
OPM
OPM%
10.113.014.518.417.020.620.217.517.216.314.613.8
NPM
NPM%
6.07.89.613.313.314.714.714.316.113.213.113.4
ROCE
ROCE%
20.617.618.522.021.823.222.420.320.816.515.315.8
ROE
ROE%
17.914.615.418.116.417.016.014.515.712.311.611.9
ROA
ROA%
8.79.210.013.313.213.813.012.413.310.39.910.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2564724214252684496236781,1731,1051,1301,025
Price To Earnings
Price To Earnings
11.016.812.28.75.27.29.09.312.613.412.910.6
Price To Sales
Price To Sales
0.61.31.21.20.71.11.31.32.01.81.71.4
Price To Book
Price To Book
1.92.51.91.60.81.21.41.42.01.61.51.3
EV To EBITDA
EV To EBITDA
7.911.18.86.73.95.06.37.211.610.711.310.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.134.541.045.446.448.048.547.046.146.947.447.4
OPM
OPM%
10.113.014.518.417.020.620.217.517.216.314.613.8
NPM
NPM%
6.07.89.613.313.314.714.714.316.113.213.113.4
ROCE
ROCE%
20.617.618.522.021.823.222.420.320.816.515.315.8
ROE
ROE%
17.914.615.418.116.417.016.014.515.712.311.611.9
ROA
ROA%
8.79.210.013.313.213.813.012.413.310.39.910.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,3821,1121,0791,025874793782
Close PriceClose₹209.27469.95320.15511.9094.87147.80223.81
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE30.6496.7052.8310.5817.25278.8732.16
Price To SalesPS4.607.181.641.422.541.923.28
RevenueRevenueCr301155656722343414239
Revenue Growth TTMRev Gr TTM%6.4%8.7%14.3%14.3%0.7%13.1%13.9%
PAT Growth TTMPAT Gr TTM%-26.6%31.4%-55.0%21.1%287.7%-68.6%-13.6%
Market CapitalizationMkt CapCr1,3821,1121,0791,025874793782
Close PriceClose₹209.27469.95320.15511.9094.87147.80223.81
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE30.6496.7052.8310.5817.25278.8732.16
Price To SalesPS4.607.181.641.422.541.923.28
RevenueRevenueCr301155656722343414239
Revenue Growth TTMRev Gr TTM%6.4%8.7%14.3%14.3%0.7%13.1%13.9%
PAT Growth TTMPAT Gr TTM%-26.6%31.4%-55.0%21.1%287.7%-68.6%-13.6%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews